OUR PRODUCTS

MOBILE APPS

GENERAL INFO

EPRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EPRX is expected to report earnings to fall 24.72% to -18 cents per share on November 05

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports

Q3'25

Est.

$-0.18

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.02

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.01

The last earnings report on August 12 showed earnings per share of -24 cents, missing the estimate of -18 cents. With 2.22K shares outstanding, the current market capitalization sits at 192.10M.

View a ticker or compare two or three

Compare

EPRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EPRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

201-2067 Cadboro Bay Road

Phone

+1 250 590-3968

Employees

Web

https://www.eupraxiapharma.com